about
Surgery and diagnostic imaging in abdominal Crohn's disease.Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phaseChallenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.Non-invasive evaluation of intestinal disorders: The role of elastographic techniques.Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer's patches to promote host-microbiota mutualism.A gut-vascular barrier controls the systemic dissemination of bacteria.Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin.PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.T-cell-directed therapies in inflammatory bowel diseases.Th17 immune response in IBD: A new pathogenic mechanism.Investigational cytokine-targeted therapies for ulcerative colitis.The CD4-centered universe of human T cell subsets.Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD "AGED study".Evolving roles of cross-sectional imaging in Crohn's disease.Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation.Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses.Interleukin-34 Induces Cc-chemokine Ligand 20 in Gut Epithelial Cells.A novel method for the culture and polarized stimulation of human intestinal mucosa explants.Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy.Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation.Absence of a role for interleukin-13 in inflammatory bowel disease.CD4+ T Helper Cell Plasticity in Infection, Inflammation, and Autoimmunity.Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21.Circulating ghrelin levels in patients with inflammatory bowel diseaseHelicobacter pylori infection associates with a mucosal downregulation of ghrelin, negative regulator of Th1-cell responses.Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C.Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation.High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases.Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells.Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut.Regulation of gut inflammation and th17 cell response by interleukin-21.Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model.Intestinal IFN-γ-producing Tr1-cells co-express CCR5 and PD-1, and down-regulate IL-10 in the inflamed gut of IBD patients.Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue.Successful Treatment With Vedolizumab in a Patient With Chronic Refractory Pouchitis and Primary Sclerosing Cholangitis.
P50
Q27000186-C7DF31EC-C44F-47B5-8314-47207778EF9BQ28280868-0DC425B9-3E76-4327-9046-ABC7BE4ADC9DQ30244767-B3EEE589-DE33-488C-A77F-114EA81A710FQ30356094-4B1BACF2-5C81-454E-8190-7F3F1A6D144CQ34904199-8A1C3CD0-4EDA-4FBA-A76E-04EE1A1B7780Q35441529-63702BC6-8682-4D02-AB75-B664AC99F94EQ35479759-9F10ECA2-D78C-4C5C-ABD4-05906B2D279CQ35840463-F5CF3C46-5EF6-4CA6-ACB8-EE5EAA0A202DQ35947790-5CA6757E-2EA2-4709-9DF6-5601FF9ACE72Q36973400-32892B39-8A38-4835-8158-4B08E00D72A9Q37720783-4E225A30-0BEC-4701-9E43-DADD466166AAQ37822505-BAD499B7-22F4-43B7-BC3F-7083896557D3Q38117175-2984A423-9317-4F4F-B5F8-EC89531748C4Q38158937-F64DF2CF-B26E-4B43-84C8-BEA0E54872F6Q38813556-6023703D-F466-486A-8673-17DD84A033D9Q38849125-89203A14-2116-42EA-8E3E-74253066BF9EQ40057258-B32AAF59-C9E4-4346-B8A3-78225472D09AQ40260379-316F6ECF-E82D-41FD-A82E-C8F21E54C667Q40317591-F699D672-32F7-442A-83FD-EBCFF1B298F5Q40451280-251BE1CE-673A-465A-B726-211CB59F2677Q41204786-44D0D5F9-8408-45BB-B36D-7E3E57B4A434Q41247751-81044249-4862-4919-876E-C26A6E33B904Q41877251-EF034D3D-9829-46C0-856F-187D3F9E9664Q42236791-51F771D5-6844-49DA-9B9B-5F1E5B911A88Q42322177-02FE1403-B4DD-434E-9686-7DA5FA36F1ACQ42844116-D6D07F80-BA94-4620-9CD7-B58EBAFF3F71Q42844932-BC75DE1F-D7D9-4365-975E-4A56E39C52F7Q43488946-26EB12BB-8D89-4051-A8B0-0B99244914CFQ44010419-99EC2F91-467A-4A2C-925C-5F1A129F9FAFQ44403344-C87AC0CE-63CB-4CA2-B190-4E0276E6B118Q45233685-59378BE8-3A93-40A5-A4CE-1B58FE078ED7Q45611689-6F31C019-E96C-461F-9B6B-79B8DF9D8C74Q45943518-2871870F-5F14-4B72-85D0-31DFAA830189Q46608300-1680438F-B90C-493F-B51F-F3B0A7A1BB2AQ46659438-F21D94CF-C2D2-4CFB-BA3E-9A9A41D6B059Q47245367-3E186161-17F0-4DCA-8CF2-416B9C27B458Q49709409-2A56D066-4044-41C5-BCF8-79497A75E339Q49818443-B6A49370-7DFD-4355-81C6-BD1E828626CEQ50105682-C135E064-23BD-4793-B118-04E16117E6BDQ50140916-AA438FCC-3D40-49CC-B093-3945C915D088
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Flavio Caprioli
@ast
Flavio Caprioli
@en
Flavio Caprioli
@es
Flavio Caprioli
@nl
Flavio Caprioli
@sl
type
label
Flavio Caprioli
@ast
Flavio Caprioli
@en
Flavio Caprioli
@es
Flavio Caprioli
@nl
Flavio Caprioli
@sl
prefLabel
Flavio Caprioli
@ast
Flavio Caprioli
@en
Flavio Caprioli
@es
Flavio Caprioli
@nl
Flavio Caprioli
@sl
P106
P1153
23134255800
P21
P31
P496
0000-0002-8077-8175